Ocean Biomedical, Inc. (OCEA) Net Cash Provided by (Used in) Financing Activities USD 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ocean Biomedical, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2021 to 2023.
  • Ocean Biomedical, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $2.92 M, a 388% increase year-over-year.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $2.92 M +$2.32 M +388% Mar 31, 2023 10-Q/A 2024-04-15
Q1 2022 $599 K Mar 31, 2022 10-Q/A 2024-04-15
Q3 2021 $109 M Sep 30, 2021 10-Q 2022-10-17
Q2 2021 -$40.2 K Jun 30, 2021 10-Q 2022-07-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.